36 related articles for article (PubMed ID: 30263497)
21. Secondary metabolites, cytotoxic response by neutral red retention and protective effect against H2O2 induced cytotoxicity of Sedum caespitosum.
Söhretoğlu D; Sabuncuoğlu S
Nat Prod Commun; 2012 Jan; 7(1):39-40. PubMed ID: 22428239
[TBL] [Abstract][Full Text] [Related]
22. Corticosteroid-induced osteoporosis: an update for dermatologists.
Clarke BL
Am J Clin Dermatol; 2012 Jun; 13(3):167-90. PubMed ID: 22393910
[TBL] [Abstract][Full Text] [Related]
23. Effects of obesity on bone metabolism.
Cao JJ
J Orthop Surg Res; 2011 Jun; 6():30. PubMed ID: 21676245
[TBL] [Abstract][Full Text] [Related]
24. Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice.
Yao W; Cheng Z; Busse C; Pham A; Nakamura MC; Lane NE
Arthritis Rheum; 2008 Jun; 58(6):1674-86. PubMed ID: 18512788
[TBL] [Abstract][Full Text] [Related]
25. Radical scavenging, antioxidant and antimicrobial activities of halophytic species.
Meot-Duros L; Le Floch G; Magné C
J Ethnopharmacol; 2008 Mar; 116(2):258-62. PubMed ID: 18164885
[TBL] [Abstract][Full Text] [Related]
26. Adipocyte differentiation from the inside out.
Rosen ED; MacDougald OA
Nat Rev Mol Cell Biol; 2006 Dec; 7(12):885-96. PubMed ID: 17139329
[TBL] [Abstract][Full Text] [Related]
27. The role of MAPKs in adipocyte differentiation and obesity.
Bost F; Aouadi M; Caron L; Binétruy B
Biochimie; 2005 Jan; 87(1):51-6. PubMed ID: 15733737
[TBL] [Abstract][Full Text] [Related]
28. The mechanisms of action of PPARs.
Berger J; Moller DE
Annu Rev Med; 2002; 53():409-35. PubMed ID: 11818483
[TBL] [Abstract][Full Text] [Related]
29. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay.
Krey G; Braissant O; L'Horset F; Kalkhoven E; Perroud M; Parker MG; Wahli W
Mol Endocrinol; 1997 Jun; 11(6):779-91. PubMed ID: 9171241
[TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells.
Gimble JM; Robinson CE; Wu X; Kelly KA; Rodriguez BR; Kliewer SA; Lehmann JM; Morris DC
Mol Pharmacol; 1996 Nov; 50(5):1087-94. PubMed ID: 8913339
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis.
Manolagas SC; Jilka RL
N Engl J Med; 1995 Feb; 332(5):305-11. PubMed ID: 7816067
[TBL] [Abstract][Full Text] [Related]
32. Adipogenesis inhibitory effects of
Kwon MS; Karadeniz F; Kim JA; Seo Y; Kong CS
Food Sci Biotechnol; 2016; 25(Suppl 1):125-131. PubMed ID: 30263497
[TBL] [Abstract][Full Text] [Related]
33. Involvement of adipogenic potential of human bone marrow mesenchymal stem cells (MSCs) in osteoporosis.
Rodríguez JP; Astudillo P; Ríos S; Pino AM
Curr Stem Cell Res Ther; 2008 Sep; 3(3):208-18. PubMed ID: 18782003
[TBL] [Abstract][Full Text] [Related]
34. Chemical Constituents, Anticancer and Anti-Proliferative Potential of
Gancedo NC; Isolani R; de Oliveira NC; Nakamura CV; de Medeiros Araújo DC; Sanches ACC; Tonin FS; Fernandez-Llimos F; Chierrito D; de Mello JCP
Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259435
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
